{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-011509","form_type":"8-K","ticker":"GCTK","cik":"0001506983","company_name":"Glucotrack, Inc.","filed_at":"2025-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.165584+00:00","generated_at":"2026-05-17T22:18:08.142363+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Glucotrack to exhibit CBGM at ADCES; touts progress toward US pilot study","bullets":["Presenting at ADCES Annual Meeting Aug 8-11, 2025 in Phoenix, AZ; CBGM at Booth #1724.","Poster: 'Endocrinologists’ Perspectives on an Implantable CBGM' on Aug 9, 12:00-1:00 PM MST.","Preparing to begin long-term early feasibility study after successful initial clinical validation.","CBGM is fully implantable, lasts up to 3 years, measures blood glucose directly with no on-body wearable."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-011509","json":"https://secwatch.observer/filing/0001493152-25-011509.json","markdown":"https://secwatch.observer/filing/0001493152-25-011509.md","text":"https://secwatch.observer/filing/0001493152-25-011509.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506983/000149315225011509/0001493152-25-011509-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506983/000149315225011509/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:18:08.142363+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}